Genmab is squaring off with Janssen in a legal battle over royalties from the multiple myeloma drug Darzalex, and shares of the Denmark-based company fell in trading after the announcement.
Gilead Sciences Inc. started two late-stage studies to test the company’s drug in patients with severe and moderate cases of the illness caused by the coronavirus, sending the drug firm’s shares up.
H. Lundbeck A/S won U.S. FDA marketing clearance for the first intravenous medication approved for the preventative treatment of migraine.
Investigators with the National Institutes of Health conducted research on monkeys that injected a bacilli Calmette-Guerin (BCG) vaccine directly into the bloodstream, producing dramatically improved effectiveness compared to injecting the vaccine into the muscle or skin.
